Valentina Leone

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS.

Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS.

Journal: Cancer cell

Published: February 01, 2026

Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response.

Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response.

Journal: Molecular systems biology

Published: April 02, 2024

HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx.

HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx.

Journal: JHEP reports : innovation in hepatology

Published: December 03, 2023

A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development.

A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development.

Journal: Nature communications

Published: September 04, 2023

Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.

Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.

Journal: Journal of hepatology

Published: February 02, 2023

A Pancreatic Cancer Patient-Derived Xenograft Model for Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes.

A Pancreatic Cancer Patient-Derived Xenograft Model for Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes.

Journal: Gastro hep advances

Published: August 23, 2022

Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Journal: Nature medicine

Published: February 19, 2022

Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.

Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.

Journal: Nature

Published: May 11, 2021

Liver Inflammation and Hepatobiliary Cancers.

Liver Inflammation and Hepatobiliary Cancers.

Journal: Trends in cancer

Published: July 17, 2020

Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.

Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.

Journal: Nature

Published: February 17, 2020

NASH limits anti-tumour surveillance in immunotherapy-treated HCC.

NASH limits anti-tumour surveillance in immunotherapy-treated HCC.

Journal: Nature

Published: February 17, 2020

A new class of protein biomarkers based on subcellular distribution: application to a mouse liver cancer model.

A new class of protein biomarkers based on subcellular distribution: application to a mouse liver cancer model.

Journal: Scientific reports

Published: February 27, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026